ID

34308

Description

Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01598740

Link

https://clinicaltrials.gov/show/NCT01598740

Keywords

  1. 1/16/19 1/16/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 16, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Heart Failure NCT01598740

Eligibility Heart Failure NCT01598740

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
heart failure with new york heart association (nyha) classification ii or iii
Description

ID.1

Data type

boolean

chronic kidney disease
Description

ID.2

Data type

boolean

cardiac ejection fraction <40%
Description

ID.3

Data type

boolean

on heart failure therapy including an acei or arb, and a bb
Description

ID.4

Data type

boolean

willing to understand and comply with study procedures and provide written informed consent.
Description

ID.5

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
hospitalization within 4 weeks of baseline visit
Description

ID.6

Data type

boolean

history or presence of gastrointestinal conditions such as severe constipation or gastrointestinal tract strictures
Description

ID.7

Data type

boolean

current or anticipated dialysis during study
Description

ID.8

Data type

boolean

in the investigator's judgment, any cardiovascular, renal, hepatic, endocrine, gastrointestinal, neurological, or other disease or condition that makes the subject's study participation unsafe
Description

ID.9

Data type

boolean

drug or alcohol abuse
Description

ID.10

Data type

boolean

Similar models

Eligibility Heart Failure NCT01598740

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
heart failure with new york heart association (nyha) classification ii or iii
boolean
ID.2
Item
chronic kidney disease
boolean
ID.3
Item
cardiac ejection fraction <40%
boolean
ID.4
Item
on heart failure therapy including an acei or arb, and a bb
boolean
ID.5
Item
willing to understand and comply with study procedures and provide written informed consent.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
hospitalization within 4 weeks of baseline visit
boolean
ID.7
Item
history or presence of gastrointestinal conditions such as severe constipation or gastrointestinal tract strictures
boolean
ID.8
Item
current or anticipated dialysis during study
boolean
ID.9
Item
in the investigator's judgment, any cardiovascular, renal, hepatic, endocrine, gastrointestinal, neurological, or other disease or condition that makes the subject's study participation unsafe
boolean
ID.10
Item
drug or alcohol abuse
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial